08.05.2024 14:00 PM GMT
Event Host
Dr Paul Craddy and Dr Graham Foxon
Event Description

Join us for the latest instalment in our EU HTA webinar series! The upcoming EU Health Technology Assessment (HTA) legislation promises to revolutionise market access for pharmaceutical manufacturers across the EU. Designed to streamline the evaluation process for health technologies, this legislation demands a strategic approach from manufacturers to ensure compliance and competitiveness in the market.

In this highly anticipated webinar, Dr. Paul Craddy and Dr. Graham Foxon, will delve into the critical transition from strategic planning to actionable steps. Drawing on their extensive experience, Remap’s managing directors will guide participants through the intricacies of incorporating EU HTA considerations into their long-term activities.

Whether you’re a seasoned industry professional or new to HTA compliance, this webinar will offer invaluable insights and actionable strategies to propel your organisation forward in the evolving EU regulatory landscape.

Don’t miss this opportunity to gain a competitive edge and position your company for success in the era of EU HTA. Save your seat today!

Plus, in the meantime, check out our EU HTA resource library here.

Register Now

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.